Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
2.
Pediatr Dermatol ; 32(3): 401-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25660236

RESUMO

Neonatal lupus erythematosus (NLE) is an autoimmune disease caused by transplacental antibodies that can damage fetal tissue and cause various findings. With the exception of congenital heart block, which can be easily recognized at birth because of neonatal cardiac monitoring during the delivery and immediately after birth, most cases of NLE are recognized within days to weeks of life, but fewer than 10 cases with findings present at birth have been reported. We report the case of a newborn with extensive cutaneous eruption at the time of birth and multisystemic involvement, including hematologic, respiratory, hepatic, and neurologic involvement.


Assuntos
Lúpus Eritematoso Sistêmico/congênito , Anormalidades Múltiplas , Biópsia , Diagnóstico Diferencial , Humanos , Recém-Nascido , Lúpus Eritematoso Sistêmico/diagnóstico , Masculino
3.
Reumatol. clín. (Barc.) ; 10(3): 170-176, mayo-jun. 2014. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-122463

RESUMO

El lupus eritematoso neonatal es una enfermedad rara del recién nacido producida por el paso transplacentario de autoanticuerpos maternos. Las 2 formas de presentación más frecuentes son la dermatológica (lupus eritematoso subagudo) y el bloqueo auriculoventricular completo (BAVC). También puede producir afectación hematológica, hepática, neurológica, respiratoria y digestiva. Presentamos una revisión de 4 casos diagnosticados en los últimos 5 a˜nos en nuestra Unidad de Neonatología, que reflejan el amplio espectro clínico con el que se puede presentar esta enfermedad (un caso de BAVC, uno con afectación multisistémica y 2 casos con expresión cutánea), los diferentes patrones de autoanticuerpos (con un predominio de anticuerpos anti-SSA), la desaparición de autoanticuerpos en todos los casos antes del año de edad y la posibilidad de aparición de colagenopatías en el futuro, como ocurrió en uno de nuestros casos (AU)


Neonatal lupus erythematosus is an infrequent disease seen in newborns. It is caused by transplacental maternal autoantibody passage. Cutaneous involvement and congenital heart block (CHB) are the most common affections, although it may involve multiple organs like the liver, lungs, blood, nervous or digestive systems. This article present a review of the four cases diagnosed in the past five years in a Neonatal Unit, which shows the different clinical spectrum which can develop around this disease (CHB, multisystemic affection and two cutaneous cases), different autoantibodies (specially anti-SSA) with an early negativization during the first year of life and the possibility of future collagen vascular disease as occurred in one case (AU)


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lúpus Eritematoso Sistêmico/epidemiologia , Autoanticorpos/isolamento & purificação , Bloqueio Cardíaco/congênito , Doenças do Colágeno/epidemiologia , Síndrome de Sjogren/epidemiologia , Fatores de Risco
4.
Reumatol Clin ; 10(3): 170-3, 2014.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-24296269

RESUMO

Neonatal lupus erythematosus is an infrequent disease seen in newborns. It is caused by transplacental maternal autoantibody passage. Cutaneous involvement and congenital heart block (CHB) are the most common affections, although it may involve multiple organs like the liver, lungs, blood, nervous or digestive systems. This article present a review of the four cases diagnosed in the past five years in a Neonatal Unit, which shows the different clinical spectrum which can develop around this disease (CHB, multisystemic affection and two cutaneous cases), different autoantibodies (specially anti-SSA) with an early negativization during the first year of life and the possibility of future collagen vascular disease as occurred in one case.


Assuntos
Lúpus Eritematoso Sistêmico/congênito , Pré-Escolar , Feminino , Seguimentos , Humanos , Recém-Nascido , Lúpus Eritematoso Sistêmico/diagnóstico , Lúpus Eritematoso Sistêmico/terapia , Masculino , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA